Chemoattractant receptor affinity reflects its ability to transduce different biological responses

Area of Science:

• Immunology
• Cellular Biology
• Biochemistry

Background:

• Oligopeptide chemotactic factor receptor in human neutrophils (PMNs) exists in two affinity states.
• Guanine nucleotides regulate receptor interconversion, but only one state is typically detected in whole cells.
• Membrane microviscosity influences chemoattractant receptor affinity.

Purpose of the Study:

• To investigate the relationship between receptor affinity states and distinct neutrophil functional responses.
• To explore the hypothesis that different affinity states initiate specific signaling pathways.
• To determine if pharmacological manipulation of receptor affinity can modulate neutrophil biological activity.

Main Methods:

• Utilized human PMNs and their membranes.
• Employed pharmacological agents like aliphatic alcohols and amphotericin B to alter membrane microviscosity and receptor affinity.
• Assessed chemotaxis, superoxide (O2-) production, and lysozyme secretion in response to chemoattractants.

Main Results:

• Aliphatic alcohols decreasing membrane microviscosity enhanced receptor affinity, increasing chemotaxis but decreasing O2- production and secretion.
• Amphotericin B, which lowered receptor affinity, depressed chemotaxis but enhanced lysozyme secretion.
• These findings demonstrate heterogeneous transduction mechanisms for chemoattractant receptor-initiated responses.

Conclusions:

• The affinity state of the oligopeptide chemotactic factor receptor correlates with specific downstream signaling pathways.
• A higher affinity state appears to mediate chemotaxis, while a lower affinity state is linked to O2- production and secretion.
• Pharmacological modulation of receptor affinity offers a potential strategy to selectively control human PMN biological functions.